This is an observational study, called The National Amyotrophic Lateral Sclerosis (ALS) Registry, that aims to learn more about ALS in the United States. It's not testing a specific drug or intervention, but rather collecting information to understand who gets ALS, what factors might be linked to it, and how it relates to other similar conditions. The study hopes to enroll 30,000 participants. Success for this study means gathering enough information to better describe ALS and its connections. The current status of the study is unclear, but it is designed to help people with ALS find clinical trials through its Research Notification System. To join, you must be a U.S. citizen aged 18 or older.

Study design

This is an observational study, meaning it collects information without testing a specific treatment. It plans to include 30,000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, which is the main goal of the study, is measured at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.